News
Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an ...
What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...
Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent ...
Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...
<p> Suvoda and Greenphire have announced the successful completion of their previously announced merger. Through this merger, the combined company is now better equipped to provide a ...
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound. According to NVIDIA, Agentic AI will ...
<p>On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, ...
A client in Ireland acquired an aseptic operations facility with plans to expand into GMP microbiology laboratory services, despite having previously outsourced all microbiology work and lacking ...
A large manufacturing client in the southeastern U.S. chose to outsource its laboratory operations to focus on its core business strategy, which involved displacing around 100 employees. To address ...
A major biopharmaceutical company faced equity and operational challenges from relying on temporary employees in long-term roles. These workers lacked full-time status and received limited, costly ...
In this interview, Steven Facer, Senior Vice President of Global Sales and Marketing at Adare Pharma Solutions, outlines the essential elements of successful CDMO partnerships in today’s fast-paced, ...
More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback